arginine has been researched along with Vascular Diseases in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (4.17) | 18.7374 |
1990's | 7 (9.72) | 18.2507 |
2000's | 24 (33.33) | 29.6817 |
2010's | 31 (43.06) | 24.3611 |
2020's | 7 (9.72) | 2.80 |
Authors | Studies |
---|---|
Bode-Böger, SM; Bornstein, SR; Burdin, D; Chen, Y; Cordasic, N; Hilgers, K; Hofmann, A; Hohenstein, B; Hugo, CPM; Jacobi, J; Jarzebska, N; Kolouschek, A; Maas, R; Markov, AG; Martens-Lobenhoffer, J; Morawietz, H; O'Sullivan, JF; Pfluecke, C; Rodionov, RN; Rubets, E; Todorov, V; Weiss, N | 1 |
Andtbacka, RHI; Hyngstrom, JR; Kwon, OS; Noh, SG; Park, SH; Richardson, RS | 1 |
Arc-Chagnaud, C; De la Rosa, A; Guerra-Ojeda, S; Mauricio, MD; San-Miguel, T; Serna, E; Valls, A; Verdú, D; Viña, J | 1 |
Drohomirecka, A; Komuda, K; Lutyńska, A; Rywik, TM; Sokołowska, D; Waś, J; Wiligórska, N; Zieliński, T | 1 |
Fukuo, K; Imamura, T; Otaki, N; Tanino, N; Yano, M; Yokoro, M | 1 |
Mariotti, F | 1 |
Chen, C; Dong, ZC; Han, X; Liang, C; Wang, QS; Wu, MM; Yan, X; Zhang, B; Zhang, YL; Zhang, ZR; Zou, LX | 1 |
Cai, W; Li, H; Li, Y; Ma, Y; Niu, X; Yang, G; Yang, N; Zhang, X; Zhao, Y; Zhou, X | 1 |
Atawia, RT; Bagi, Z; Bhatta, A; Caldwell, RB; Caldwell, RW; Chen, J; Fouda, AY; Lucas, R; Toque, HA; Xu, Z; Yao, L | 1 |
Cantin, C; Carvajal, L; Contreras-Duarte, S; Fuenzalida, B; Gutiérrez, J; Leiva, A; Salsoso, R; Sobrevia, B; Sobrevia, L | 1 |
Huml, M; Jehlička, P; Kreslová, M; Masopustová, A; Sýkora, J; Trefil, L; Votava, T | 1 |
Brodmann, M; Gary, T; Hackl, G; Hafner, F; Jud, P; Meinitzer, A; Seinost, G; Verheyen, N | 1 |
Ando, R; Fukami, K; Kaida, Y; Kaifu, K; Miyazaki, H; Nakayama, Y; Obara, N; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S; Yokoro, M | 1 |
Aranguez, I; Fernández-Alfonso, MS; García-Prieto, CF; Gil-Ortega, M; Kreutz, R; Pulido-Olmo, H; Ruiz-Hurtado, G; Schönfelder, G; Schulz, A; Somoza, B; Steireif, C | 1 |
Ballard, KD; Bruno, RS; Guo, Y; Mah, E; Pei, R; Volek, JS | 1 |
Elenkova, A; Kirilov, G; Matrozova, J; Vandeva, S; Vasilev, V; Zacharieva, S | 1 |
Blanco-Colio, LM; Carrero, JJ; Cetinkaya, H; Eyileten, T; Gok, M; Oguz, Y; Saglam, M; Sari, S; Sonmez, A; Unal, HU; Vural, A; Yaman, H; Yildirim, AO; Yilmaz, MI | 1 |
Gard, PR; Nilforooshan, R; Richardson, C; Tabet, N; Weaving, G | 1 |
Charakida, M; Chinetti-Gbaguidi, G; Colin, S; Deanfield, JE; Fliser, D; Hettrich, I; Landmesser, U; Long, D; McLoughlin, E; O'Neill, F; Rohrer, L; Shanahan, CM; Shroff, R; Speer, T; Staels, B; Zewinger, S | 1 |
Lappegård, KT; Nestvold, TK; Nielsen, EW; Seljeflot, I; Thoresen, H; Trøseid, M | 1 |
Bramanti, P; Calabrò, RS; Gervasi, G | 1 |
Chaturapanich, G; Lukkhananan, P; Sibmooh, N; Srihirun, S; Swaddiwudhipong, W; Thawonrachat, N; Unchern, S; Visoottiviseth, P; Vivithanaporn, P | 1 |
Brinkmann, SJ; van Leeuwen, PA; Wörner, EA | 1 |
Hoe, KL; Jeon, BH; Jeon, YG; Kim, YM; Lim, HK; Nguyen, MC; Park, JT; Ryoo, S | 1 |
Arpaci, D; Ciftci, IH; Ergenc, H; Gurol, G; Karakece, E; Tamer, A; Tocoglu, AG | 1 |
Boyarsky, VG; Kolpakov, IY; Stepanova, YI; Zyhalo, VM | 1 |
Bierhansl, L; Carmeliet, P; Conradi, LC; Dewerchin, M; Treps, L | 1 |
Dichgans, M; Freilinger, T; Opherk, C; Peters, N; Pfefferkorn, T | 1 |
Boneh, A; Coman, D; Yaplito-Lee, J | 1 |
Dhondt, A; Glorieux, G; Leybaert, L; Schepers, E; Vanholder, R | 1 |
Alpert, DR; Cooke, JP; Crow, MK; Devereux, RB; Lockshin, MD; Perna, M; Roman, MJ; Salmon, JE; Sammaritano, L | 1 |
Brasacchio, D; Chin-Dusting, J; Cooper, ME; Coughlan, MT; Forbes, JM; Harris, E; Kaye, D; Paavonen, K; Soro-Paavonen, A; Thomas, MC; Tong, DC; Venardos, K; Zhang, WZ | 1 |
Förstermann, U | 1 |
Máñez, S; Marín, M | 1 |
Smythe, MA; Warkentin, TE; Woodhouse, AL; Zakalik, D | 1 |
Bassareo, PP; Deidda, M; Fanos, V; Flore, G; Manconi, E; Melis, A; Mercuro, G; Puddu, M | 1 |
Barroso, M; Blom, HJ; Castro, R; de Almeida, IT; Esse, R; Gomes, AQ; Gonçalves, I; Jakobs, C; Loscalzo, J; Rivera, I; Rocha, MS; Teerlink, T | 1 |
Bleich, S; Frieling, H; Haschemi-Nassab, M; Hillemacher, T; Kornhuber, J; Leitmeier, V; Rhein, M | 1 |
Desai, K; Dhar, A; Dhar, I; Wu, L | 1 |
Colak, Y; Coskunpinar, E; Doganay, L; Kahraman, OT; Mesci, B; Ozturk, O; Senates, E; Tuncer, I; Ulasoglu, C; Yesil, A; Yilmaz, Y | 1 |
Asif, M; Mangoni, AA; McEvoy, M; Soiza, RL | 1 |
Ballas, SK; Davis-Moon, L; Kreshak, AA; Lopez, BL; Ma, XL; Morris, CR | 1 |
Merhi, Y; Tabrizian, M; Thierry, B; Winnik, FM | 1 |
FRANZINI, C | 1 |
ZOELLNER, N | 1 |
Fareed, J; Jeske, WP | 1 |
Kreuzer, J; Tiefenbacher, CP | 1 |
McCarty, MF | 2 |
Barton, M | 1 |
Stanger, O; Stühlinger, MC | 1 |
Feindel, CM; Mallidi, H; Miriuka, S; Ramzy, D; Rao, V; Tumiati, LC; Xu, N | 1 |
Sela, BA | 1 |
Jia, SJ; Jiang, DJ; Li, YJ; Yan, J; Yuan, Q; Zhou, Z | 1 |
Wang, YQ; Zheng, YN | 1 |
Cooke, JP; Konishi, H; Sydow, K | 1 |
Sim, AS; Wang, J; Wang, XL; Wilcken, DE | 1 |
Nanayakkara, PW; Stehouwer, CD; van Guldener, C | 1 |
Desai, A; Warren, JS; Zhao, Y | 1 |
Chin, C; Cooke, JP; Fearon, WF; Holweg, C; Lewis, DB; Luikart, H; Mocarski, ES; Potena, L; Sydow, K; Valantine, HA; Weisshaar, D | 1 |
Fujino, H; Ikeda, K; Kubota, A; Nara, Y; Numano, F; Tagami, M; Yamori, Y | 1 |
Moncada, S | 1 |
Andoh, TF; Bennett, WM; Gardner, MP | 1 |
Arnal, JF; Darblade, B; Dinh-Xuan, AT; Pueyo, M; Rami, J | 1 |
Cosentino, F; Lüscher, TF | 1 |
Kelm, M; Strauer, BE | 1 |
Kuypers, FA; Larkin, S; Morris, CR; Simon, J; Styles, LA; Sweeters, N; Vichinsky, EP | 1 |
Fedele, D; Lapolla, A; Traldi, P | 1 |
Maxwell, AJ | 1 |
Fushimi, H; Kobayashi, Y; Koyama, T; Matsuyuki, Y; Miyata, M; Shima, K; Sugase, T; Tarui, S; Yamada, T | 1 |
Berkenboom, G; Fang, ZY; Fontaine, J; Goldman, M; Unger, P | 1 |
Seiter, K | 1 |
20 review(s) available for arginine and Vascular Diseases
Article | Year |
---|---|
Arginine supplementation and cardiometabolic risk.
Topics: Arginine; Biological Availability; Cardiometabolic Risk Factors; Diabetes Mellitus, Type 2; Dietary Supplements; Endothelium, Vascular; Humans; Vascular Diseases | 2020 |
L-Arginine and vascular diseases: lights and pitfalls!
Topics: Arginine; Humans; Vascular Diseases | 2014 |
Central Role of Metabolism in Endothelial Cell Function and Vascular Disease.
Topics: Animals; Arginine; Endothelial Cells; Fatty Acids; Glutamine; Glycogen; Glycolysis; Hexosamines; Humans; Neovascularization, Pathologic; Neovascularization, Physiologic; Pentose Phosphate Pathway; Vascular Diseases | 2017 |
New indications and controversies in arginine therapy.
Topics: Acidosis, Lactic; Amino Acid Metabolism, Inborn Errors; Arginine; Central Nervous System; Creatine; Dietary Supplements; Humans; MELAS Syndrome; Mitochondrial Myopathies; Nitric Oxide; Vascular Diseases | 2008 |
Nitric oxide and oxidative stress in vascular disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Arginine; Aryldialkylphosphatase; Biopterins; Calcium; Cardiovascular Diseases; Catalase; Electron Transport; Glutathione Peroxidase; Heme Oxygenase (Decyclizing); Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitochondria; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Protein Multimerization; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Superoxide Dismutase; Superoxides; Thioredoxins; Vascular Diseases; Xanthine Oxidase | 2010 |
Pharmacological interventions on asymmetric dimethylarginine, a clinical marker of vascular disease.
Topics: Adrenergic Antagonists; Angiotensins; Arginine; Diabetes Complications; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperhomocysteinemia; Hypertension; Kidney Diseases; Microcirculation; Nitric Oxide Synthase Type III; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Vascular Diseases | 2011 |
Asymmetric dimethylarginine: a possible link between vascular disease and dementia.
Topics: Arginine; Brain; Dementia; Endothelium; Enzyme Inhibitors; Humans; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Risk Factors; Vascular Diseases | 2013 |
Small-molecule direct antithrombins: argatroban.
Topics: Animals; Antithrombins; Arginine; Hemostasis; Humans; Pipecolic Acids; Sulfonamides; Treatment Outcome; Vascular Diseases | 2004 |
Nitric oxide-mediated endothelial dysfunction--is there need to treat?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Clinical Trials as Topic; Endothelium, Vascular; Homocysteine; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nitric Oxide; Vascular Diseases | 2003 |
Ageing as a determinant of renal and vascular disease: role of endothelial factors.
Topics: Aging; Arginine; Endothelial Cells; Endothelium, Vascular; Humans; Kidney Diseases; Nitric Oxide; Vascular Diseases | 2005 |
Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Topics: Animals; Arginine; Arteriosclerosis; Endothelium, Vascular; Homocysteine; Humans; Hyperhomocysteinemia; Nitric Oxide; Vascular Diseases | 2005 |
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.
Topics: Arginine; Citrulline; Dietary Supplements; Hepatocytes; Homocysteine; Humans; Kidney Diseases; Liver Diseases; Nitric Oxide Synthase; Obesity; Risk Factors; Vascular Diseases | 2007 |
Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.
Topics: Arginine; Homocysteine; Humans; Kidney Failure, Chronic; Vascular Diseases | 2007 |
The L-arginine: nitric oxide pathway, cellular transduction and immunological roles.
Topics: Arginine; Humans; Macrophages; Nitric Oxide; Signal Transduction; Vascular Diseases | 1993 |
Endothelium-derived nitric oxide and vascular physiology and pathology.
Topics: Animals; Arginine; Arteriosclerosis; Blood Vessels; Caveolin 1; Caveolins; Cell Adhesion; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Humans; Hypertension; Hypertension, Pulmonary; Isoenzymes; Membrane Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oxidative Stress; Rabbits; Signal Transduction; Vascular Diseases; Vasodilation | 1999 |
Tetrahydrobiopterin and endothelial nitric oxide synthase activity.
Topics: Antioxidants; Arginine; Biopterins; Citrulline; Coronary Vessels; Endothelium, Vascular; Enzyme Activation; Humans; Nitric Oxide; Nitric Oxide Synthase; Oxidation-Reduction; Vascular Diseases | 1999 |
[Endothelial dysfunction. Therapeutic and prognostic issues].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Arginine; Endothelial Growth Factors; Endothelium, Vascular; Estrogen Replacement Therapy; Exercise; Fibrinolytic Agents; Humans; Hypolipidemic Agents; Nitric Oxide; Prognosis; Smoking Cessation; Vascular Diseases | 1999 |
AGE in micro- and macroangiopathy.
Topics: Aging; Animals; Arginine; Arteriosclerosis; Cell Adhesion; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Interferon-gamma; Lysine; Membrane Proteins; Microcirculation; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; T-Lymphocytes; Vascular Diseases | 2001 |
Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases.
Topics: Animals; Arginine; Endothelium, Vascular; Humans; Kinetics; Nitric Oxide; Nitric Oxide Synthase; Polymorphism, Genetic; Signal Transduction; Vascular Diseases | 2002 |
Toxicity of the topoisomerase II inhibitors.
Topics: Antineoplastic Agents; Cardiovascular Diseases; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Epirubicin; Etoposide; Humans; Idarubicin; Leukemia; Middle Aged; Mitoxantrone; Mucositis; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors; Vascular Diseases | 2005 |
2 trial(s) available for arginine and Vascular Diseases
Article | Year |
---|---|
Low-fat milk ingestion prevents postprandial hyperglycemia-mediated impairments in vascular endothelial function in obese individuals with metabolic syndrome.
Topics: Adult; Animals; Area Under Curve; Arginine; Blood Glucose; Brachial Artery; Cross-Over Studies; Diet; Dietary Fats; Double-Blind Method; Endothelium, Vascular; Fasting; Female; Humans; Hyperglycemia; Lipid Peroxidation; Male; Malondialdehyde; Metabolic Syndrome; Milk; Nitric Oxide; Obesity; Oryza; Oxidative Stress; Plant Preparations; Postprandial Period; Vascular Diseases; Vasodilation | 2013 |
Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL.
Topics: Adult; Arginine; Blood Flow Velocity; Blood Pressure; CADASIL; Cerebrovascular Circulation; Endothelium; Female; Heart Rate; Humans; Male; Middle Aged; Middle Cerebral Artery; Receptor, Notch3; Receptors, Notch; Severity of Illness Index; Ultrasonography, Doppler, Transcranial; Vascular Diseases | 2008 |
50 other study(ies) available for arginine and Vascular Diseases
Article | Year |
---|---|
Overexpression of alanine-glyoxylate aminotransferase 2 protects from asymmetric dimethylarginine-induced endothelial dysfunction and aortic remodeling.
Topics: Amidohydrolases; Animals; Aorta; Arginine; Blood Pressure; Mice; Transaminases; Vascular Diseases | 2022 |
Ageing and endothelium-mediated vascular dysfunction: the role of the NADPH oxidases.
Topics: Acetylcholine; Aging; Arginine; Endothelium, Vascular; Humans; Middle Aged; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Vascular Diseases | 2023 |
Glucose 6-P Dehydrogenase Overexpression Improves Aging-Induced Endothelial Dysfunction in Aorta from Mice: Role of Arginase II.
Topics: Aging; Animals; Aorta; Arginase; Arginine; Endothelium, Vascular; Glucose; Glucosephosphate Dehydrogenase; Male; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Vascular Diseases | 2023 |
L-arginine and Its Derivatives Correlate with Exercise Capacity in Patients with Advanced Heart Failure.
Topics: Arginine; Biomarkers; Exercise Tolerance; Heart Failure; Heart Transplantation; Humans; Vascular Diseases | 2023 |
Association between asymmetric dimethylarginine and sarcopenia in community-dwelling older women.
Topics: Aged; Arginine; Female; Humans; Independent Living; Sarcopenia; Vascular Diseases | 2023 |
The vascular endothelial growth factor trap aflibercept induces vascular dysfunction and hypertension via attenuation of eNOS/NO signaling in mice.
Topics: Animals; Aorta; Arginine; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Signal Transduction; Vascular Diseases | 2021 |
Systemic Evaluation of Vascular Dysfunction by High-Resolution Sonography in an N
Topics: Animals; Arginine; Blood Flow Velocity; Carotid Artery, Common; Disease Models, Animal; Female; Femoral Artery; Mice; Mice, Inbred C57BL; Placental Circulation; Pre-Eclampsia; Pregnancy; Reproducibility of Results; Ultrasonography, Prenatal; Umbilical Arteries; Vascular Diseases | 2018 |
Obesity-induced vascular dysfunction and arterial stiffening requires endothelial cell arginase 1.
Topics: Animals; Arginase; Arginine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Sucrose; Endothelium, Vascular; Enzyme Inhibitors; Fibrosis; Genetic Predisposition to Disease; Insulin; Male; Metabolic Syndrome; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Obesity; Ornithine; Oxidative Stress; Phenotype; Signal Transduction; Vascular Diseases; Vascular Stiffness; Vasodilation | 2017 |
Maternal supraphysiological hypercholesterolemia associates with endothelial dysfunction of the placental microvasculature.
Topics: Adult; Arginase; Arginine; Case-Control Studies; Cells, Cultured; Endothelium, Vascular; Female; Humans; Hypercholesterolemia; Microvessels; Nitric Oxide; Nitric Oxide Synthase Type III; Placenta; Pregnancy; Vascular Diseases | 2018 |
Plethysmographic and biochemical markers in the diagnosis of endothelial dysfunction in pediatric acute lymphoblastic leukemia survivors - new applications.
Topics: Adolescent; Arginine; Biomarkers; C-Reactive Protein; Child; E-Selectin; Endothelium, Vascular; Female; Humans; Male; Plethysmography; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Female; Homoarginine; Humans; Incidence; Lower Extremity; Male; Middle Aged; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction.
Topics: Aged; Amidohydrolases; Arginine; Atherosclerosis; Cells, Cultured; Diabetic Nephropathies; Endothelial Cells; Female; Glycation End Products, Advanced; Humans; Male; Middle Aged; Nitric Oxide; Reactive Oxygen Species; Vascular Diseases | 2013 |
Dissecting the genetic predisposition to albuminuria and endothelial dysfunction in a genetic rat model.
Topics: Acetylcholine; Albuminuria; Animals; Aorta; Arginine; Endothelium, Vascular; Genetic Predisposition to Disease; Indomethacin; Male; Nitric Oxide; Quantitative Trait Loci; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides; Vascular Diseases | 2013 |
Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1(sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Arginine; Biomarkers; Blood Glucose; Blood Pressure; Catecholamines; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Pheochromocytoma; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2013 |
Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.
Topics: Adult; Arginine; Biomarkers; Brachial Artery; C-Reactive Protein; Cytokine TWEAK; Endothelium, Vascular; Female; Humans; Kidney Transplantation; Male; Postoperative Period; Prospective Studies; Renal Insufficiency, Chronic; Tumor Necrosis Factors; Vascular Diseases; Vasodilation | 2013 |
Impaired renal function and biomarkers of vascular disease in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arginine; Biomarkers; Case-Control Studies; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kidney Diseases; Male; Mental Status Schedule; Multivariate Analysis; Risk Factors; Vascular Diseases | 2014 |
HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.
Topics: Adolescent; Arginine; Biomarkers; Child; Cholesterol, HDL; Cholesterol, LDL; Endothelium, Vascular; Female; Humans; Kidney Transplantation; Male; Nitric Oxide; Renal Dialysis; Renal Insufficiency, Chronic; Triglycerides; Vascular Diseases | 2014 |
Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients.
Topics: Adipose Tissue; Adult; Age Factors; Arginine; Bariatric Surgery; Biomarkers; Female; Humans; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Middle Aged; Monocytes; Obesity; Prospective Studies; Risk Factors; Sex Factors; Vascular Diseases | 2015 |
Endothelial dysfunction in subjects with chronic cadmium exposure.
Topics: Arginine; Biomarkers; Cadmium Compounds; Endothelium, Vascular; Environmental Exposure; Female; Glutathione; Humans; Linear Models; Malondialdehyde; Nitrites; Thrombomodulin; Vascular Diseases | 2015 |
Strict glucose control and artificial regulation of the NO-ADMA-DDAH system in order to prevent endothelial dysfunction.
Topics: Amidohydrolases; Arginine; Glucose; Humans; Nitric Oxide; Vascular Diseases | 2016 |
Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
Topics: Animals; Arginase; Arginine; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Phosphorylation; Reactive Oxygen Species; Vascular Diseases | 2016 |
Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
Topics: Adult; Arginine; Biomarkers; Demography; Endothelium, Vascular; Female; Humans; Hypothyroidism; Inflammation; Male; Neoplasm Proteins; Proteoglycans; Risk Factors; Thyroid Function Tests; Transforming Growth Factor beta; Vascular Diseases | 2016 |
Correction of endothelial dysfunction in children residents of radioactively contaminated areas by nitric oxide donator.
Topics: Arginine; Brachial Artery; Child; Endothelial Cells; Humans; Nitric Oxide; Vascular Diseases; Vasodilation | 2016 |
Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Arginine; Calcium; Calcium Channel Blockers; Calcium Channels; Captopril; Edetic Acid; Enzyme Inhibitors; Humans; Imidazoles; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Reactive Oxygen Species; Respiratory Burst; Thapsigargin; Vascular Diseases | 2009 |
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients.
Topics: Adult; Aging; Arginine; Carotid Arteries; Female; Homocysteine; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Multivariate Analysis; Patient Selection; Prognosis; Severity of Illness Index; Vascular Diseases | 2010 |
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
Topics: Animals; Aorta, Thoracic; Arginine; Cattle; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Glycation End Products, Advanced; Hypoglycemic Agents; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Vascular Diseases; Vasodilation; Vasodilator Agents | 2010 |
Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome.
Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin | 2011 |
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction?
Topics: Adolescent; Adult; Arginine; Early Diagnosis; Endothelium, Vascular; Female; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Low Birth Weight; Infant, Newborn; Male; Predictive Value of Tests; Premature Birth; Vascular Diseases; Young Adult | 2012 |
Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells.
Topics: Arginine; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Hyperhomocysteinemia; Methylation; Nitric Oxide; Nitric Oxide Synthase Type III; S-Adenosylhomocysteine; Vascular Diseases | 2012 |
Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal.
Topics: Adult; Alcoholism; Arginine; Diagnostic and Statistical Manual of Mental Disorders; Germany; Homocysteine; Humans; Hyperhomocysteinemia; International Classification of Diseases; Male; Middle Aged; Nitric Oxide Synthase; Pilot Projects; Prospective Studies; Risk Factors; Severity of Illness Index; Substance Withdrawal Syndrome; Time Factors; Vascular Diseases | 2012 |
Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
Topics: Animals; Aorta; Arginase; Arginine; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Glucose; Human Umbilical Vein Endothelial Cells; Humans; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Nitric Oxide Synthase Type III; Oxidative Stress; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vascular Diseases; Vasodilation | 2012 |
Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
Topics: Adult; Arginine; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; Case-Control Studies; Early Diagnosis; Endothelium, Vascular; Fatty Liver; Female; Humans; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Practice Guidelines as Topic; Predictive Value of Tests; Severity of Illness Index; Vascular Diseases; Vasodilation | 2013 |
L-arginine levels are diminished in adult acute vaso-occlusive sickle cell crisis in the emergency department.
Topics: Acute Disease; Adult; Anemia, Sickle Cell; Arginine; Biomarkers; Constriction, Pathologic; Humans; Nitric Oxide; Pain Measurement; Vascular Diseases | 2003 |
Nanocoatings onto arteries via layer-by-layer deposition: toward the in vivo repair of damaged blood vessels.
Topics: Animals; Arginine; Chitin; Chitosan; Endothelium, Vascular; Hyaluronic Acid; Microscopy, Confocal; Nanotechnology; Platelet Adhesiveness; Swine; Vascular Diseases | 2003 |
[Action of L-arginine on the behavior of blood ammonia in liver disease patients].
Topics: Ammonia; Arginine; Humans; Liver Diseases; Vascular Diseases | 1960 |
[On the behavior of the blood ammonia and its precursors in liver diseases and on the modification of these substances by arginine and glucose].
Topics: Ammonia; Arginine; Glucose; Humans; Liver Diseases; Vascular Diseases | 1959 |
Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
Topics: Amidohydrolases; Arginine; Biomarkers; Catalysis; Clinical Trials as Topic; Endothelium, Vascular; Evidence-Based Medicine; Humans; Models, Cardiovascular; Oxidative Stress; Vascular Diseases | 2004 |
Coping with endothelial superoxide: potential complementarity of arginine and high-dose folate.
Topics: Administration, Oral; Animals; Arginine; Clinical Trials as Topic; Dietary Supplements; Dose-Response Relationship, Drug; Drug Combinations; Endothelium, Vascular; Evidence-Based Medicine; Folic Acid; Humans; Models, Biological; Models, Cardiovascular; Nitric Oxide; Superoxides; Vascular Diseases | 2004 |
Cardiac allograft preservation using donor-shed blood supplemented with L-arginine.
Topics: Animals; Arginine; Biomarkers; Biopsy; Blood Transfusion, Autologous; Cell Adhesion Molecules; Coronary Vessels; Endothelium, Vascular; Heart Transplantation; Intercellular Signaling Peptides and Proteins; Models, Animal; Myocardium; Organ Preservation; Oxidative Stress; Perfusion; Recovery of Function; Swine; Transplantation, Homologous; Vascular Diseases; Vasomotor System; Ventricular Function, Left | 2005 |
[ADMA (asymmetric dimethylarginine)--the inhibitor of nitric oxide (NO) synthesis: a new marker for vascular pathology].
Topics: Arginine; Biomarkers; Humans; Nitric Oxide; Nitric Oxide Synthase; Vascular Diseases; Vasoconstriction | 2005 |
Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
Topics: Amidohydrolases; Animals; Arginine; Calcium; Endothelium, Vascular; Humans; Male; Nicotine; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; RNA, Messenger; Vascular Diseases | 2006 |
[Dimethylarginine dimethylaminohydrolase and endothelium dysfunction].
Topics: Amidohydrolases; Animals; Arginine; Endothelium, Vascular; Humans; Vascular Diseases | 2006 |
Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
Topics: Amidohydrolases; Animals; Arginine; Cell Proliferation; Disease Models, Animal; Endothelium, Vascular; Enzyme Induction; Femoral Artery; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Physiologic; Nitric Oxide; Probability; Random Allocation; Sensitivity and Specificity; Species Specificity; Vascular Diseases | 2007 |
Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Topics: Amidohydrolases; Animals; Arginine; Base Sequence; Cells, Cultured; DNA Primers; Endothelial Cells; Epoetin Alfa; Erythropoietin; Humans; Kidney; Kidney Failure, Chronic; Liver; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Recombinant Proteins; Up-Regulation; Vascular Diseases | 2008 |
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.
Topics: Adult; Aged; Arginine; Biomarkers; Heart Transplantation; Humans; Hyperplasia; Immunosuppressive Agents; Longitudinal Studies; Middle Aged; Sirolimus; Transplantation, Homologous; Tunica Intima; Ultrasonography; Vascular Diseases | 2008 |
Detailed examination of vascular lesions triggered by an inhibitor of endothelium-derived relaxing factor.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Blood Pressure; Blood Vessels; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Hydralazine; Hypertension, Renovascular; Incidence; Microscopy, Electron; Nitric Oxide; Nitroarginine; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium; Thrombosis; Time Factors; Vascular Diseases | 1995 |
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Fibrosis; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Diseases | 1997 |
Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease.
Topics: Acute Disease; Arginine; Case-Control Studies; Humans; Nitric Oxide; Prospective Studies; Sickle Cell Trait; Syndrome; Vascular Diseases | 2000 |
Endocrine function in a case of beta-adrenergic hyperdynamic circulatory state.
Topics: Arginine; Blood Glucose; Cyclic AMP; Female; Glucagon; Growth Hormone; Humans; Hypertension; Insulin; Mandelic Acids; Metanephrine; Middle Aged; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Syndrome; Vascular Diseases | 1976 |
Prevention of cyclosporine A-induced vascular toxicity by pentoxifylline.
Topics: Acetylcholine; Animals; Arginine; Colforsin; Cyclosporine; Endothelium, Vascular; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Neuromuscular Depolarizing Agents; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pentoxifylline; Phenylephrine; Rats; Rats, Inbred Strains; Vascular Diseases | 1991 |